SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63365 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62874re: GLUE volume. On the useless factoid front.... Today will skew the ADV for qerickerickson-10/28/2024
62873re: GLUE from: Monte Rosa Therapeutics Announces Global License Agreement witherickerickson210/28/2024
62872MRNS: Bought in at $1.54. Sold out at $0.57 premarket. R.I.P.ghettogoulash-10/25/2024
62871Thanks. Appreciate explanationDavidoff110/21/2024
62870Primarily because AD is such a tough nut to crack. The idea that this small molstockdoc77310/21/2024
62869I'm curious if you say 90% remain on drug after study, and if you believe thDavidoff110/21/2024
62868No insight on MRNS. I bought some after the plunge in April, but I see that Avorghettogoulash-10/19/2024
62867To pull a drug in P3 that has almost finished the trial when there is no safety stockdoc77210/19/2024
62866Makes the sale to Gilead look better and better with hindsight. Behzad got us tstockdoc77810/19/2024
62865ca.finance.yahoo.commannamal-10/18/2024
62864Not surprisingly that article is pretty one sided IMO.erippetoe-10/13/2024
62863doximity.comurslor-10/13/2024
62862finance.yahoo.comjargonweary-10/10/2024
62861Jargon, is that GILD's Q2 results? Seems early for Q3 to be released alreadKeeptheFaith-10/10/2024
62860From Gilead’s earnings call: Gilead's oncology segment showed strong growthjargonweary710/10/2024
62859finance.yahoo.comsysiphus-10/10/2024
62858For any of those in the Florida region, especially Tampa area and surrounding ..luckydog88310/8/2024
62857HC Wainwright & Co. analyst Vernon Bernardino upgrades Cassava Sciences(SAVAluckydog88410/8/2024
62856An Open Letter from President and CEO Rick Barry to the Cassava Community: Patiluckydog88410/8/2024
62855I remember GhettoGoulash was looking closely at MRNS in the spring when MRNS solOlecranon-10/7/2024
62854Does anyone here still follow Marinus? (MRNS) They’re due to report top line datSwedishlake-10/6/2024
62853science.orgurslor310/6/2024
62852SEC: "the results no longer show a significant difference between placebo, ghettogoulash-9/30/2024
62851Funny how the FDA inspected Wang's lab, his Elisa machine, time stamped dataghettogoulash29/30/2024
62850SAVA: Live Short Interest is 40% of the float, or 17M shares. The most compellinghettogoulash19/30/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News